Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043): ErratumJournal of acquired immune deficiency syndromes (1999), 2018-04, Vol.77 (5), p.e48-e48 [Peer Reviewed Journal]Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved. ;Copyright Lippincott Williams & Wilkins Ovid Technologies Apr 15, 2018 ;ISSN: 1525-4135 ;EISSN: 1944-7884 ;DOI: 10.1097/QAI.0000000000001672 ;PMID: 29521876Full text available |
|
2 |
Material Type: Article
|
The new generation hdhodh inhibitor meds433 hinders the in vitro replication of sars-cov-2 and other human coronavirusescc by (c) Calistri, Arianna et al, 2021 http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess ;ISSN: 2076-2607 ;EISSN: 2076-2607 ;DOI: 10.3390/microorganisms9081731Full text available |
|
3 |
Material Type: Article
|
Metabolic, mitochondrial, renal and hepatic safety of enfuvirtide and raltegravir antiretroviral administration: Randomized crossover clinical trial in healthy volunteerscc-by (c) Barroso, Sergio et al., 2019 http://creativecommons.org/licenses/by/3.0/es info:eu-repo/semantics/openAccess ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0216712Full text available |
|
4 |
Material Type: Article
|
Mpox in people with advanced HIV infection: a global case seriesThe Lancet (British edition), 2023-03, Vol.401 (10380), p.939-949 [Peer Reviewed Journal]2023 Elsevier Ltd ;Copyright © 2023 Elsevier Ltd. All rights reserved. ;2023. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(23)00273-8 ;PMID: 36828001Full text available |
|
5 |
Material Type: Article
|
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trialsThe Lancet (British edition), 2019-01, Vol.393 (10167), p.143-155 [Peer Reviewed Journal]2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32462-0 ;PMID: 30420123Full text available |
|
6 |
Material Type: Article
|
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysisThe Lancet infectious diseases, 2022-12, Vol.22 (12), p.1748-1755 [Peer Reviewed Journal]2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(22)00499-6 ;PMID: 36049486Full text available |
|
7 |
Material Type: Article
|
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational studyThe Lancet (British edition), 2019-06, Vol.393 (10189), p.2428-2438 [Peer Reviewed Journal]2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2019. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. ;2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2019 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)30418-0 ;PMID: 31056293Full text available |
|
8 |
Material Type: Article
|
Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021Nature medicine, 2021-12, Vol.27 (12), p.2085-2098 [Peer Reviewed Journal]2021. Springer Nature America, Inc. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature America, Inc. 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01590-5 ;PMID: 34848888Full text available |
|
9 |
Material Type: Article
|
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysisThe Lancet infectious diseases, 2017-08, Vol.17 (8), p.873-881 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 1, 2017 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(17)30243-8 ;PMID: 28483415Full text available |
|
10 |
Material Type: Article
|
Coronavirus: the spread of misinformationBMC medicine, 2020-03, Vol.18 (1), p.89-89, Article 89 [Peer Reviewed Journal]COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-020-01556-3 ;PMID: 32188445Full text available |
|
11 |
Material Type: Article
|
Defective HIV-1 proviruses produce viral proteinsProceedings of the National Academy of Sciences - PNAS, 2020-02, Vol.117 (7), p.3704-3710 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Feb 18, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1917876117 ;PMID: 32029589Full text available |
|
12 |
Material Type: Article
|
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysisThe Lancet infectious diseases, 2018-03, Vol.18 (3), p.346-355 [Peer Reviewed Journal]2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;Copyright Elsevier Limited Mar 1, 2018 ;2018. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2018 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(17)30702-8 ;PMID: 29198909Full text available |
|
13 |
Material Type: Article
|
Assessing the Virologic Impact of Archived Resistance in the Dolutegravir/Lamivudine 2-Drug Regimen HIV-1 Switch Study TANGO through Week 144cc by (c) Wang, Ruolan et al, 2023 http://creativecommons.org/licenses/by/3.0/es/ info:eu-repo/semantics/openAccess ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v15061350Full text available |
|
14 |
Material Type: Article
|
Achieving the 95 95 95 targets for all: A pathway to ending AIDSPloS one, 2022-08, Vol.17 (8), p.e0272405-e0272405 [Peer Reviewed Journal]COPYRIGHT 2022 Public Library of Science ;2022 Frescura et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Frescura et al 2022 Frescura et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0272405 ;PMID: 35925943Full text available |
|
15 |
Material Type: Article
|
HIVThe Lancet (British edition), 2018-08, Vol.392 (10148), p.685-697 [Peer Reviewed Journal]2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;COPYRIGHT 2018 Elsevier B.V. ;2018. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31311-4 ;PMID: 30049419Full text available |
|
16 |
Material Type: Article
|
Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ARTNature communications, 2020-08, Vol.11 (1), p.4089-4089, Article 4089 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-17898-8 ;PMID: 32796830Full text available |
|
17 |
Material Type: Article
|
Proliferation of latently infected CD4 + T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamicsThe Journal of experimental medicine, 2017-04, Vol.214 (4), p.959-972 [Peer Reviewed Journal]2017 Hosmane et al. ;Copyright Rockefeller University Press Apr 3, 2017 ;2017 Hosmane et al. 2017 ;ISSN: 0022-1007 ;EISSN: 1540-9538 ;DOI: 10.1084/jem.20170193 ;PMID: 28341641Full text available |
|
18 |
Material Type: Article
|
Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 CureCell, 2013-10, Vol.155 (3), p.540-551 [Peer Reviewed Journal]2013 Elsevier Inc. ;Copyright © 2013 Elsevier Inc. All rights reserved. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2013.09.020 ;PMID: 24243014Full text available |
|
19 |
Material Type: Article
|
Definition of Immunological Nonresponse to Antiretroviral Therapy: A Systematic Review: ErratumJournal of acquired immune deficiency syndromes (1999), 2020-04, Vol.83 (4), p.e28-e28 [Peer Reviewed Journal]Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved. ;Copyright Lippincott Williams & Wilkins Ovid Technologies Apr 1, 2020 ;ISSN: 1525-4135 ;EISSN: 1944-7884 ;DOI: 10.1097/QAI.0000000000002312 ;PMID: 32097198Full text available |
|
20 |
Material Type: Article
|
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority studyThe Lancet (British edition), 2020-12, Vol.396 (10267), p.1994-2005 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32666-0 ;PMID: 33308425Full text available |